Showing results (411-420 of 735) with videos related to
Sort By:
Pageof 74
The Oncologist|July 2, 2026
Molecular Tumor Board-Guided Osimertinib Therapy in EGFR L858R/Q701L-Mutant Lung Adenocarcinoma Supported by Functional ValidationCorinna Albers-Leischner, Matthias Ritgen, Finn-Ole Paulsen, et al.World Journal of Urology|February 28, 2022
First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment : A comprehensive review compiled by the German Testicular Cancer Study GroupDavid Pfister, Karin Oechsle, Stefanie Schmidt, et al.Purinergic Signalling|August 10, 2019
The P2-receptor-mediated Ca2+ signalosome of the human pulmonary endothelium - implications for pulmonary arterial hypertensionJan K Hennigs, Nicole Lüneburg, Annett Stage, et al.British Journal of Haematology|February 24, 2005
Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosisNicolaus Kröger, Tatjana Zabelina, Heike Schieder, et al.Onkologie|April 18, 2008
A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC)Michael Görn, Christian R Habermann, Manuela Anige, et al.Journal of Neuroimmunology|May 23, 2006
Acute psychological stress alerts the adaptive immune response: stress-induced mobilization of effector T cellsDjordje Atanackovic, Benjamin Schnee, Gunter Schuch, et al.Journal of Proteomics|March 1, 2015
Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkersRamesh Ummanni, Divya Duscharla, Christine Barett, et al.Oncotarget|April 24, 2018
Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancerSergey A Dyshlovoy, Katharina Otte, Kseniya M Tabakmakher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
[18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study groupKarin Oechsle, Michael Hartmann, Winfried Brenner, et al.Cancer Medicine|July 1, 2023
Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatmentMatthäus Majewski, Pia Paffenholz, Christian Ruf, et al.Pageof 74